Arcus Biosciences Inc. RCUS
$23.62
▲ +2.15% 24H
About
Arcus Biosciences Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. Focusing primarily on immuno-oncology, the company aims to harness the body's own immune system to target and eliminate cancer cells. Arcus Biosciences' pipeline includes a variety of monoclonal antibodies, small …
SectorHealthcare
ExchangeNYSE
IndustryBiotechnology
CountryUnited States
Employees601
TickerRCUS
Statistics
Market Cap$2.96B
Revenue (TTM)$247.0M
Net Income-$353.0M
Net Margin-142.9%
EPS$-3.29
P/E-7.23
P/S12.42
P/B5.58
EV/EBITDA-5.33
ROE-70.0%
Dividend Yield—
Price$23.62
Data: Twelve Data · Revenue = mcap / P/S